Eli Lilly & Co. closed $199.24 short of its 52-week high ($972.53), which the company achieved on August 22nd.

CWA Asset Management Group LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 11.9% in ...

We recently compiled a list of the Tech Billionaire Chase Coleman's Top 10 Stock Picks. In this article, we are going to take a look at where Eli Lilly and Co (NYSE ... his strategic portfolio ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Jr. on air last week on the floor when President-elect Trump visited the New York Stock Exchange. I asked him ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Eli Lilly fair value estimate is US$1,319 Current share ...

In contrast to all that, many investors prefer to focus on companies like Eli Lilly (NYSE:LLY), which has not only revenues, but also profits. While profit isn't the sole metric that should be ...

Eli Lilly's robust product portfolio, strategic acquisitions, and innovation-led initiatives drive its strong growth, positioning it well in the weight-loss, immunology, and oncology markets.

Just one successful drug or device can propel a biotech company to new heights ... is Eli Lilly (LLY), a global pharmaceutical leader that has been a standout performer in the stock market ...

Shares of Eli Lilly climbed Wednesday after the drugmaker ... stories from wire services such as the Associated Press, The New York Times, The Washington Post or Bloomberg News.

The New York Times has published the most inane op-ed after the shooting of the UnitedHealthcare CEO. The New Republic Down 20%, This Is My Top High-Yield Dividend Stock to Buy Before the New Year ...